A 56-year-old female with uncontrolled diabetes (A1c 9.1%), chronic kidney disease stage 3a (eGFR 54 mL/min/1.73 m²), currently taking amoxicillin‑clavulanate for bacterial rhinosinusitis, now presents with severe diarrhea; how should this be managed?

Management of Severe Diarrhea in a Patient on Amoxicillin-Clavulanate with Uncontrolled Diabetes and CKD Stage 3a

Stop the amoxicillin-clavulanate immediately and test for Clostridioides difficile infection, as this patient's severe diarrhea is most likely antibiotic-associated and requires urgent evaluation given her immunocompromised status post bone marrow transplant. 1

Immediate Antibiotic Management

• Discontinue amoxicillin-clavulanate now – the FDA drug label explicitly warns that diarrhea is a common problem caused by antibacterials, and patients can develop watery and bloody stools even as late as 2 or more months after the last dose. 1

• If diarrhea is severe or lasts more than 2-3 days, contact the physician immediately – this is a direct FDA warning that applies to your patient's current presentation. 1

• Amoxicillin-clavulanate causes diarrhea in a significantly higher proportion of patients – one randomized trial showed patients taking amoxicillin-clavulanate were nearly 4 times more likely to have diarrhea (odds ratio 3.89,95% CI 2.09-7.25) compared to placebo at 7 days. 2

C. difficile Testing Protocol

• Test stool for C. difficile toxin immediately – this patient meets high-risk criteria: recent antibiotic exposure (amoxicillin-clavulanate), immunocompromised status (post bone marrow transplant), and severe diarrhea. 3

• If C. difficile is confirmed and severe, start oral vancomycin 125 mg four times daily for 10 days – vancomycin is superior to metronidazole in all cases of CDI, including severe disease (Recommendation 1A). 3

• Fidaxomicin 200 mg twice daily for 10 days is an alternative – especially appropriate given her immunocompromised status and higher risk for recurrence (Recommendation 1A). 3

Critical Medication Review: Metformin Management

Hold metformin immediately during this acute illness – the patient's severe diarrhea constitutes an acute volume-depletion state that mandates temporary metformin discontinuation regardless of her baseline eGFR of 54 mL/min/1.73 m². 3, 4

Why Metformin Must Be Stopped Now

• KDOQI guidelines explicitly recommend temporary discontinuation of metformin in patients with eGFR <60 mL/min/1.73 m² who have serious intercurrent illness that increases the risk of acute kidney injury – severe diarrhea qualifies as such an illness. 3

• Severe diarrhea, vomiting, and dehydration are specific conditions requiring immediate metformin hold – these volume-depletion states markedly reduce metformin clearance and increase lactic acidosis risk. 3, 4

• Her baseline eGFR of 54 mL/min/1.73 m² (CKD stage 3a) already places her in a higher-risk category – acute illness superimposed on moderate CKD substantially elevates the risk of metformin accumulation. 3, 4

When to Restart Metformin

• Do not restart metformin until all of the following criteria are met:

  • Diarrhea has completely resolved
  • Patient is adequately hydrated and tolerating oral intake
  • eGFR has been re-checked and remains ≥30 mL/min/1.73 m²
  • No ongoing acute illness 3, 4

• Once restarted, continue at her current dose if eGFR remains 45-59 mL/min/1.73 m² – no dose reduction is mandatory in this range, but monitor eGFR every 3-6 months. 3, 4

• If eGFR has dropped to 30-44 mL/min/1.73 m² during the acute illness, reduce metformin dose by 50% (maximum 1000 mg daily) when restarting. 3, 4

Alternative Sinusitis Treatment

• Switch to a respiratory fluoroquinolone (levofloxacin 750 mg daily for 5 days) or doxycycline 100 mg twice daily for 5-7 days – both are effective alternatives for bacterial rhinosinusitis and have lower rates of diarrhea than amoxicillin-clavulanate. 3

• Ensure adequate hydration and continue nasal saline rinses – supportive measures remain important even when changing antibiotics. 3

Diabetes Management During Acute Illness

• Monitor blood glucose closely during metformin hold – expect glucose levels to rise temporarily without metformin. 3

• Consider short-acting insulin coverage if glucose exceeds 250 mg/dL – this provides safe glycemic control during the acute illness without hypoglycemia risk. 3

• Do NOT add sulfonylureas or other hypoglycemia-prone agents during acute illness – the risk of hypoglycemia is unacceptably high in the setting of poor oral intake and diarrhea. 3

Renal Function Monitoring

• Recheck basic metabolic panel (BMP) within 24-48 hours – assess for acute kidney injury, electrolyte disturbances (especially hypokalemia from diarrhea), and volume status. 3, 4

• If creatinine rises or eGFR drops below 45 mL/min/1.73 m², do not restart metformin at full dose – dose reduction to maximum 1000 mg daily will be required. 3, 4

Common Pitfalls to Avoid

• Do not continue metformin "because her baseline eGFR is acceptable" – acute illness overrides baseline renal function considerations for metformin safety. 3, 4

• Do not assume the diarrhea will resolve on its own while continuing the antibiotic – amoxicillin-clavulanate is the likely culprit and must be stopped. 1, 2

• Do not delay C. difficile testing in an immunocompromised patient – her post-transplant status significantly increases both the risk and severity of CDI. 3

• Do not restart metformin without confirming adequate hydration and stable renal function – premature restart during ongoing diarrhea or volume depletion risks lactic acidosis. 3, 4